Gujarat Themis Biosyn Ltd (GUJTHEM) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 925632, "name": "Guj. Themis Bio.", "stock_name": "Guj. Themis Bio.", "full_name": "Gujarat Themis Biosyn Ltd", "name_url": "stocks-analysis/guj-themis-bio", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "381.00", "chg": -4.4, "chgp": "-1.14%", "dir": -1, "prev_price": "385.40", "mcapval": "4,151.58 Cr", "mcap": "Small Cap", "scripcode": 506879, "symbol": "GUJTHEM", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "sector_id": 65, "indexname": "India SENSEX", "isin": "INE942C01045", "curr_date": "Jun 11, 02:38 PM", "curr_time": "14:40 PM", "last_traded_at": "Jun 11, 02:38 PM IST", "bse_nse_vol": "32.28 k", "exc_status": "Active", "traded_date": "Jun 11, 2026", "traded_date_str": "2026 06 11", "score": "", "scoreText": "", "Live": 1, "market_time": 1, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/guj-themis-bio-925632-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Gujarat Themis Biosyn Ltd Downgraded to Sell Amid Technical and Financial Concerns", "link": "https://www.marketsmojo.com/news/stock-recommendation/gujarat-themis-biosyn-ltd-downgraded-to-sell-amid-technical-and-financial-concerns-4030246", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GujaratThemisBi_mojoScore_4030246.png", "date": "2026-06-02 09:01:52", "description": "Gujarat Themis Biosyn Ltd has been downgraded from a Hold to a Sell rating as of 1 June 2026, reflecting a shift in technical indicators and valuation metrics despite its strong long-term returns. The company’s Mojo Score has declined to 42.0, with a corresponding Mojo Grade of Sell, driven primarily by deteriorating technical trends and concerns over flat recent financial performance." }, { "title": "Gujarat Themis Biosyn Ltd Faces Technical Momentum Shift Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-ltd-faces-technical-momentum-shift-amid-mixed-indicator-signals-4029686", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/GujaratThemisBi_technicaldot_4029686.png", "date": "2026-06-02 08:07:59", "description": "Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a mildly bullish to a mildly bearish stance. This transition is underscored by a complex interplay of technical indicators including MACD, RSI, moving averages, and Bollinger Bands, signalling a nuanced outlook for investors as the stock navigates recent volatility." }, { "title": "Gujarat Themis Biosyn Ltd Gains 9.56%: 5 Key Factors Driving the Week’s Volatility", "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-ltd-gains-956-5-key-factors-driving-the-weeks-volatility-4023002", "imagepath": "", "date": "2026-05-30 14:02:40", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>25 May:</strong> Intraday high surge to Rs.401.3 with 7.28% gain</p>\n <p><strong>26 May:</strong> Downgrade to Sell amid mixed financial and technical signals</p>\n <p><strong>27 May:</strong> Intraday high of Rs.402.95 with 7.23% surge; technical momentum shifts</p>\n <p><strong>28 May:</strong> Upgrade to Hold reflecting cautious optimism</p>\n <p><strong>29 May:</strong> Intraday low amid price pressure; stock closes at Rs.404.10 (-6.78%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-val..." }, { "title": "Gujarat Themis Biosyn Ltd Hits Intraday Low Amid Price Pressure", "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-ltd-hits-intraday-low-amid-price-pressure-4020738", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GujaratThemisBi_priceRelatedfactors_4020738.png", "date": "2026-05-29 15:31:36", "description": "Gujarat Themis Biosyn Ltd experienced a notable intraday decline on 29 May 2026, touching a low of Rs 400.5, down 7.61% from previous levels. The stock underperformed its sector and broader market indices amid widespread selling pressure and a bearish market environment." }, { "title": "Gujarat Themis Biosyn Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/gujarat-themis-biosyn-ltd-upgraded-to-hold-amid-mixed-financial-and-technical-signals-4017765", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GujaratThemisBi_mojoScore_4017765.png", "date": "2026-05-28 08:19:08", "description": "Gujarat Themis Biosyn Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable shift in technical indicators and sustained strong returns despite flat recent financial performance. The upgrade, effective from 27 May 2026, is driven by improvements in technical trends, solid management efficiency, and a robust long-term return profile, positioning the small-cap pharmaceutical firm as a more attractive proposition for investors seeking stability in a volatile sector." }, { "title": "Gujarat Themis Biosyn Ltd Surges 7.23% to Day's High of Rs 402.95 — Outperforms Sector by 6.65 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-ltd-hits-intraday-high-with-723-surge-on-27-may-2026-4016859", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GujaratThemisBi_priceRelatedfactors_4016859.png", "date": "2026-05-27 12:31:23", "description": "The Sensex edged down by 0.08% on 27 May 2026, while Gujarat Themis Biosyn Ltd surged 7.23%, marking a notable outperformance of 6.65 percentage points over its Pharmaceuticals & Biotechnology sector. The stock also touched an intraday high of Rs 402.95, a 9.35% jump from its previous close, underscoring a strong single-session performance that demands a closer look at the underlying technical and market context." }, { "title": "Gujarat Themis Biosyn Ltd Technical Momentum Shifts Amid Mixed Indicator Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/gujarat-themis-biosyn-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-4015778", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GujaratThemisBi_technicaldot_4015778.png", "date": "2026-05-27 08:04:13", "description": "Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with bullish signals on weekly charts contrasting with some bearish monthly trends. This article analyses the latest price movements, technical indicators, and market context to provide a comprehensive view for investors." }, { "title": "Are Gujarat Themis Biosyn Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-gujarat-themis-biosyn-ltd-latest-results-good-or-bad-4014899", "imagepath": "", "date": "2026-05-26 19:28:27", "description": "Gujarat Themis Biosyn Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company reported a net profit of ₹10.89 crores, reflecting a decline of 12.60% compared to the previous quarter and a year-on-year decrease of 9.25%. This profit contraction occurred despite a revenue growth of 1.98% quarter-on-quarter and 17.20% year-on-year, indicating that while the company is generating more sales, it is struggling to maintain profitability.\n\nThe operating profit margin, excluding other income, contracted significantly to 43.77%, down from 49.14% in the previous quarter, marking a notable 537 basis points compression. This decline in margins raises concerns about the sustainability of the company's profitability, especially given its historically strong margin profile.\n\nAdditionally, the company's return on equity (ROE) has declined to 18.07%, which is substantially..." }, { "title": "Gujarat Themis Biosyn Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals", "link": "https://www.marketsmojo.com/news/stock-recommendation/gujarat-themis-biosyn-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-4012969", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/GujaratThemisBi_mojoScore_4012969.png", "date": "2026-05-26 08:44:33", "description": "Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 May 2026. This change reflects a combination of flat recent financial performance, expensive valuation metrics, and a shift in technical indicators signalling caution for investors." } ], "total": 409, "sid": "925632", "stock_news_url": "https://www.marketsmojo.com/news/gujarat-themis-biosyn-925632" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "09-Jun-2026", "details": "Newspaper Publication of Postal Ballot Notice dated 6th June 2026", "source": "BSE" }, { "caption": "Board Meeting Outcome for Outcome Of The Board Meeting Held On 6Th June 2026", "datetime": "06-Jun-2026", "details": "Please refer to the attachment.", "source": "BSE" }, { "caption": "Shareholder Meeting / Postal Ballot-Scrutinizers Report", "datetime": "05-Jun-2026", "details": "Voting Results on Postal Ballot through e-voting and Scrutinizers Report dated 04th June 2026.", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Gujarat Themis Biosyn Ltd has declared <strong>67%</strong> dividend, ex-date: 04 Sep 25", "dt": "2025-09-04", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Gujarat Themis Biosyn Ltd has announced <strong>1:5</strong> stock split, ex-date: 10 Oct 23", "dt": "2023-10-10", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Gujarat Themis Biosyn Ltd has announced <strong>1:2</strong> bonus issue, ex-date: 09 Aug 24", "dt": "2024-08-09", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

25 May: Intraday high surge to Rs.401.3 with 7.28% gain

26 May: Downgrade to Sell amid mixed financial and technical signals

27 May: Intraday high of Rs.402.95 with 7.23% surge; technical momentum shifts

28 May: Upgrade to Hold reflecting cautious optimism

29 May: Intraday low amid price pressure; stock closes at Rs.404.10 (-6.78%)

Week Open

Read full news article

Gujarat Themis Biosyn Ltd Hits Intraday Low Amid Price Pressure

2026-05-29 15:31:36

Gujarat Themis Biosyn Ltd experienced a notable intraday decline on 29 May 2026, touching a low of Rs 400.5, down 7.61% from previous levels. The stock underperformed its sector and broader market indices amid widespread selling pressure and a bearish market environment.

Read full news article

Gujarat Themis Biosyn Ltd Upgraded to Hold Amid Mixed Financial and Technical Signals

2026-05-28 08:19:08

Gujarat Themis Biosyn Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable shift in technical indicators and sustained strong returns despite flat recent financial performance. The upgrade, effective from 27 May 2026, is driven by improvements in technical trends, solid management efficiency, and a robust long-term return profile, positioning the small-cap pharmaceutical firm as a more attractive proposition for investors seeking stability in a volatile sector.

Read full news article

Gujarat Themis Biosyn Ltd Surges 7.23% to Day's High of Rs 402.95 — Outperforms Sector by 6.65 Percentage Points

2026-05-27 12:31:23

The Sensex edged down by 0.08% on 27 May 2026, while Gujarat Themis Biosyn Ltd surged 7.23%, marking a notable outperformance of 6.65 percentage points over its Pharmaceuticals & Biotechnology sector. The stock also touched an intraday high of Rs 402.95, a 9.35% jump from its previous close, underscoring a strong single-session performance that demands a closer look at the underlying technical and market context.

Read full news article

Gujarat Themis Biosyn Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-05-27 08:04:13

Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a notable shift in its technical momentum, moving from a sideways trend to a mildly bullish stance. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the stock’s technical indicators present a complex picture, with bullish signals on weekly charts contrasting with some bearish monthly trends. This article analyses the latest price movements, technical indicators, and market context to provide a comprehensive view for investors.

Read full news article

Are Gujarat Themis Biosyn Ltd latest results good or bad?

2026-05-26 19:28:27

Gujarat Themis Biosyn Ltd's latest financial results for Q4 FY26 present a complex picture of operational performance. The company reported a net profit of ₹10.89 crores, reflecting a decline of 12.60% compared to the previous quarter and a year-on-year decrease of 9.25%. This profit contraction occurred despite a revenue growth of 1.98% quarter-on-quarter and 17.20% year-on-year, indicating that while the company is generating more sales, it is struggling to maintain profitability. The operating profit margin, excluding other income, contracted significantly to 43.77%, down from 49.14% in the previous quarter, marking a notable 537 basis points compression. This decline in margins raises concerns about the sustainability of the company's profitability, especially given its historically strong margin profile. Additionally, the company's return on equity (ROE) has declined to 18.07%, which is substantially...

Read full news article

Gujarat Themis Biosyn Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-05-26 08:44:33

Gujarat Themis Biosyn Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Hold to Sell as of 25 May 2026. This change reflects a combination of flat recent financial performance, expensive valuation metrics, and a shift in technical indicators signalling caution for investors.

Read full news article